Global Epinephrine Injection Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Epinephrine Injection market size will reach US$ million by 2031.
Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017.
United States market for Epinephrine Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Epinephrine Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Epinephrine Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Epinephrine Injection players cover Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Epinephrine Injection Industry Forecast” looks at past sales and reviews total world Epinephrine Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Epinephrine Injection sales for 2025 through 2031. With Epinephrine Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Epinephrine Injection industry.
This Insight Report provides a comprehensive analysis of the global Epinephrine Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Epinephrine Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Epinephrine Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Epinephrine Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Epinephrine Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Epinephrine Injection market by product type, application, key players and key regions and countries.
Segmentation by Type:
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Segmentation by Application:
Anaphylaxis
Cardiac Arrest
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Mylan Inc
Impax
ALK Abello
Lincoln Medical Ltd
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group
Please note: The report will take approximately 2 business days to prepare and deliver.
Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017.
United States market for Epinephrine Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Epinephrine Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Epinephrine Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Epinephrine Injection players cover Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Epinephrine Injection Industry Forecast” looks at past sales and reviews total world Epinephrine Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Epinephrine Injection sales for 2025 through 2031. With Epinephrine Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Epinephrine Injection industry.
This Insight Report provides a comprehensive analysis of the global Epinephrine Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Epinephrine Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Epinephrine Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Epinephrine Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Epinephrine Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Epinephrine Injection market by product type, application, key players and key regions and countries.
Segmentation by Type:
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Segmentation by Application:
Anaphylaxis
Cardiac Arrest
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Mylan Inc
Impax
ALK Abello
Lincoln Medical Ltd
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
106 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Epinephrine Injection Market Size by Player
- 4 Epinephrine Injection by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Epinephrine Injection Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
